JPRN-UMIN000023733
Completed
Phase 1
Pilot study "International collaborative investigation of underlying technology to develop information exchange platform with hairdresser and barber for successful aging in Thailand and Japan" - Barber Project
Overview
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- Akita University
- Enrollment
- 12
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- ot applicable to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Shop owner: disagree with our research aim Customer: disagree with our research aim
Investigators
Similar Trials
Completed
Phase 4
An international collaborative study to discontinue Imatinib/Glivec® in pediatric CML patients with sustained complete molecular responsechronic myeloid leukemia10024324NL-OMON39021Stichting Kinderoncologie Nederland6
Active, not recruiting
Not Applicable
An international collaborative study to discontinue Imatinib/Glivec® in pediatric CML patients with sustained complete molecular response(STOPIMAPED)Chronic Myeloid Leukemia pediatric patients treated with Imatinib having achieved and maintained complete molecular remission for at least 2 years.Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2011-006239-44-NLDutch Childhood Oncology Group60
Recruiting
Phase 1
International study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastinestandard risk ALK-positive anaplastic large cell lymphoma (ALCL)Therapeutic area: Diseases [C] - Neoplasms [C04]CTIS2022-501454-11-00GPOH gGmbH132
Recruiting
Phase 3
International cooperative prospective study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of VinblastineDRKS00023541Gesellschaft für pädiatrische Hämatologie und Onkologie (GPOH) gGmbH106
Not yet recruiting
Phase 3
International cooperative prospective study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastine.NL-OMON51961German Pediatric Oncology Group (GPOH) gGmbH10